<DOC>
	<DOCNO>NCT01037647</DOCNO>
	<brief_summary>Type 2 diabetes associate diabetic dyslipidemia , major risk factor coronary heart disease . Triglycerides ( TG ) cholesterol transport system lipoproteins , metabolism lipid plasma closely interrelate . Evidence suggest increase concentration low-density lipoprotein triglyceride ( VLDL-TG ) central pathophysiological feature lipid lipoprotein abnormality diabetic dyslipidemia . The objective study investigate VLDL-TG kinetics aspects peripheral VLDL-TG metabolism , i.e . extent VLDL-TG associate fatty acid ( FA ) oxidize deposited regional adipose tissue , subject type 2 diabetes healthy control postabsorptive state acute hyperinsulinemia use ex-vivo label VLDL-TG tracer .</brief_summary>
	<brief_title>VLDL-triglyceride Kinetics Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Known disease except type 2 diabetes ( type 2 diabetic subject ) Smoking Alcohol abuse Prescription medication expect oral antidiabetic ( type 2 diabetic subject )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Diabetic dyslipidemia</keyword>
	<keyword>VLDL-TG kinetics</keyword>
	<keyword>VLDL-TG metabolism</keyword>
</DOC>